Cargando…

Efficacy of system l amino acid transporter 1 inhibition as a therapeutic target in esophageal squamous cell carcinoma

System l amino acid transporter 1 (LAT1) is highly expressed in various types of human cancer, and contributes to cancer growth and survival. Recently, we have shown that LAT1 expression is closely related to the growth and aggressiveness of esophageal cancer, and is an independent marker of poor pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohshima, Yasuhiro, Kaira, Kyoichi, Yamaguchi, Aiko, Oriuchi, Noboru, Tominaga, Hideyuki, Nagamori, Shushi, Kanai, Yoshikatsu, Yokobori, Takehiko, Miyazaki, Tatsuya, Asao, Takayuki, Tsushima, Yoshito, Kuwano, Hiroyuki, Ishioka, Noriko S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084656/ https://www.ncbi.nlm.nih.gov/pubmed/27465934 http://dx.doi.org/10.1111/cas.13021

Ejemplares similares

Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma
por: Isoda, Atsushi, et al.
Publicado: (2014)

Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer
por: Kaira, Kyoichi, et al.
Publicado: (2013)

Specific transport of 3‐fluoro‐l‐α‐methyl‐tyrosine by LAT1 explains its specificity to malignant tumors in imaging
por: Wei, Ling, et al.
Publicado: (2016)

Biological significance of fluorine-18-α-methyltyrosine (FAMT) uptake on PET in patients with oesophageal cancer
por: Suzuki, S, et al.
Publicado: (2014)

Uptake of positron emission tomography tracers reflects the tumor immune status in esophageal squamous cell carcinoma
por: Kuriyama, Kengo, et al.
Publicado: (2020)

Fucosylated α(1)-acid glycoprotein as a biomarker to predict prognosis following tumor immunotherapy of patients with lung cancer
por: Yokobori, Takehiko, et al.
Publicado: (2019)

Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer
por: Toyoda, M, et al.
Publicado: (2014)

Monitoring of Current Cancer Therapy by Positron Emission Tomography and Possible Role of Radiomics Assessment
por: Oriuchi, Noboru, et al.
Publicado: (2022)

Establishment of Stable Cell Lines With High Expression of Heterodimers of Human 4F2hc and Human Amino Acid Transporter LAT1 or LAT2 and Delineation of Their Differential Interaction With α-Alkyl Moieties
por: Khunweeraphong, Narakorn, et al.
Publicado: (2012)

ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer
por: Shimizu, K, et al.
Publicado: (2014)

Simple But Efficacious Enrichment of Integral Membrane Proteins and Their Interactions for In-Depth Membrane Proteomics
por: Kongpracha, Pornparn, et al.
Publicado: (2022)

Individual dosimetry system for targeted alpha therapy based on PHITS coupled with microdosimetric kinetic model
por: Sato, Tatsuhiko, et al.
Publicado: (2021)

High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients
por: Bai, Tuya, et al.
Publicado: (2017)

High expression of carcinoembryonic antigen and telomerase reverse transcriptase in circulating tumor cells is associated with poor clinical response to the immune checkpoint inhibitor nivolumab
por: Bao, Halin, et al.
Publicado: (2018)

Ratiometric fluorescence imaging of cell surface pH by poly(ethylene glycol)-phospholipid conjugated with fluorescein isothiocyanate
por: Ohgaki, Ryuichi, et al.
Publicado: (2017)

Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer
por: Kaira, K, et al.
Publicado: (2012)

Fucosylated Glycans in α1-Acid Glycoprotein for Monitoring Treatment Outcomes and Prognosis of Cancer Patients
por: Yazawa, Shin, et al.
Publicado: (2016)

Nonclinical study and applicability of the absorbed dose conversion method with a single biodistribution measurement for targeted alpha-nuclide therapy
por: Sakashita, Tetsuya, et al.
Publicado: (2021)

Inhibition of cancer-type amino acid transporter LAT1 suppresses B16-F10 melanoma metastasis in mouse models
por: Shi, Zitong, et al.
Publicado: (2023)

Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation
por: Quan, Lili, et al.
Publicado: (2020)

Resection of an esophageal schwannoma with thoracoscopic surgery: a case report
por: Watanabe, Takayoshi, et al.
Publicado: (2016)

Postprandial cardiogenic syncope caused by gastric polyp-induced pyloric obstruction in an elderly woman with a giant hiatal hernia: a case report
por: Saito, Hideyuki, et al.
Publicado: (2017)

Cardiac imaging with (18)F-fluorodeoxyglucose PET/MRI in hypertrophic cardiomyopathy
por: Takeishi, Yasuchika, et al.
Publicado: (2016)

Immuno-PET imaging for non-invasive assessment of cetuximab accumulation in non-small cell lung cancer
por: Yamaguchi, Aiko, et al.
Publicado: (2019)

Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB(0,+), LAT1 and LAT2
por: Wongthai, Printip, et al.
Publicado: (2015)

Prognostic value of metabolic tumor volume of pretreatment (18)F-FAMT PET/CT in non-small cell lung Cancer
por: Kumasaka, Soma, et al.
Publicado: (2018)

Surgical management for achalasia after coronary artery bypass graft using the right gastroepiploic artery: a case report
por: Muranushi, Ryo, et al.
Publicado: (2017)

Multimodality Therapy Including Proton Beam Therapy for AFP Producing Esophageal Cancer with Multiple Liver Metastases
por: Miyazaki, Tatsuya, et al.
Publicado: (2018)

FF‐10832 enables long survival via effective gemcitabine accumulation in a lethal murine peritoneal dissemination model
por: Higuchi, Tamami, et al.
Publicado: (2019)

Association of L-type amino acid transporter 1 (LAT1) with the immune system and prognosis in invasive breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2022)

Coexistence of superficial carcinogenesis of resident epithelium besides neuroendocrine neoplasm of the digestive tract
por: Kuwano, Hiroyuki, et al.
Publicado: (2022)

NRFL-1, the C. elegans NHERF Orthologue, Interacts with Amino Acid Transporter 6 (AAT-6) for Age-Dependent Maintenance of AAT-6 on the Membrane
por: Hagiwara, Kohei, et al.
Publicado: (2012)

Umbilical hernia with cholelithiasis and hiatal hernia: a clinical entity similar to Saint’s triad
por: Yamanaka, Takahiro, et al.
Publicado: (2015)

Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine
por: Bilguun, Erkhem-Ochir, et al.
Publicado: (2020)

Skeletal muscle mass predicts the outcome of nivolumab treatment for non-small cell lung cancer
por: Tsukagoshi, Mariko, et al.
Publicado: (2020)

Establishment of a novel method to evaluate peritoneal microdissemination and therapeutic effect using luciferase assay
por: Takahashi, Ryo, et al.
Publicado: (2016)

Thin-Shelled PEGylated Perfluorooctyl Bromide Nanocapsules for Tumor-Targeted Ultrasound Contrast Agent
por: Achmad, Arifudin, et al.
Publicado: (2018)

An abdominal spacer that does not require surgical removal and allows drainage of abdominal fluids in patients undergoing carbon ion radiotherapy
por: Kubo, Norio, et al.
Publicado: (2020)

Differentiation of malignant tumours from granulomas by using dynamic [(18)F]-fluoro-L-α-methyltyrosine positron emission tomography
por: Yamaguchi, Aiko, et al.
Publicado: (2015)

Diagnostic value of (18)F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8(+)tumour-infiltrating lymphocytes in oral squamous cell carcinoma
por: Togo, Maria, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eccb8ru4a425pfl4us5lu7vqk5